Results
eNauka >
Rezultati >
A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3.
| Naziv: | A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3. | Autori  : | Zhang, Jianjun; ...; Andric, Zoran   ; ...; (broj, koautora 20) |
Godina: | 2025 | Publikacija: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X Journal of Clinical Oncology Pretraži identifikator |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 43 br. 16_suppl str. TPS8664-TPS8664 | DOI: | 10.1200/JCO.2025.43.16_suppl.TPS8664 | WoS-ID: | 001690381400046 | URI: | https://enauka.gov.rs/handle/123456789/1031828 | Projekat: | Summit Therapeutics, Inc. | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.